Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide

Fig. 1

TAs and arsenic speciation by time on and off ATO in patients’ plasma (a), urine (b), hair (c) and nails (d). TAs and arsenic speciation were pointed at mean value for each group. The reference lines in black and red were mean ± Standard Deviation (SD) for TAs and iAsIII of the healthy controls, respectively. TAs: total arsenic; ATO: arsenic trioxide; iAsIII: inorganic arsenite

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us